reglab/housing_qa huggingface dataset:
32 ME Rev Stat § 13792 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13792. Sale by certain methods prohibited

 §13792. Sale by certain methods prohibited 1.  Methods of sale prohibited.  A person may not sell, distribute, vend or otherwise dispose of any drug, medicine or pharmaceutical or medical preparation by means of any public exhibition, entertainment, performance, carnival or by vending machines, except as described in subsection 2.   [PL 2019, c. 454, §2 (NEW).] 2.  Sale of nonprescription drugs by vending machines.  The Maine Board of Pharmacy shall adopt rules to allow a pharmacy licensed as a vending machine outlet in accordance with section 13751 to sell or distribute nonprescription drugs by vending machines. The rules must include, but are not limited to, the following:   A. A requirement that only nonprescription drugs may be dispensed by a vending machine;   [PL 2019, c. 454, §2 (NEW).]B. A requirement that nonprescription drugs dispensed by a vending machine must be stored in accordance with manufacturer recommendations, including those that require a stable temperature;   [PL 2019, c. 454, §2 (NEW).]C. A requirement that nonprescription drugs dispensed by a vending machine must be sold only in the manufacturer's clearly labeled, original, unbroken, tamper‑proof and expiration‑dated packaging;   [PL 2019, c. 454, §2 (NEW).]D. A requirement that nonprescription drugs dispensed by a vending machine may not be older than the manufacturer's expiration date;   [PL 2019, c. 454, §2 (NEW).]E. A limitation that no more than 12 different nonprescription drugs may be dispensed by any single vending machine;   [PL 2019, c. 454, §2 (NEW).]F. A requirement that a vending machine through which nonprescription drugs are dispensed must have an obvious and legible statement on the machine that identifies the owner of the machine, a toll‑free telephone number at which the consumer may contact the owner of the machine, a statement advising the consumer to check the expiration date of the product before using the product and the telephone number of the board;   [PL 2019, c. 454, §2 (NEW).]G. Identification of any nonprescription drugs that may not be dispensed by a vending machine; and   [PL 2019, c. 454, §2 (NEW).]H. Identification of locations at which a vending machine dispensing nonprescription drugs may not be located, including the following:   (1) Private schools as defined in Title 20‑A, section 1, subsection 22;   (2) Public preschool programs as defined in Title 20‑A, section 1, subsection 23‑A;   (3) Public schools as defined in Title 20‑A, section 1, subsection 24; and   (4) Child care facilities as defined in Title 22, section 8301‑A, subsection 1‑A, paragraph B.   [PL 2019, c. 454, §2 (NEW).][PL 2019, c. 454, §2 (NEW).] SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 2019, c. 454, §2 (RPR).
32 ME Rev Stat § 13793 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13793. Adulterating and selling drugs

 §13793. Adulterating and selling drugs Whoever fraudulently adulterates, for the purpose of sale, any drug or medicine or sells any fraudulently adulterated drug or medicine, knowing the same to be adulterated, shall be punished by a fine of not more than $1,000 or by imprisonment for not more than 11 months. These adulterated drugs and medicines shall be forfeited and destroyed under the direction of the court.   [PL 1987, c. 710, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW).
32 ME Rev Stat § 13794 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13794. Labeling of prescriptions

 §13794. Labeling of prescriptions Every drug dispensed pursuant to prescription, whether for a legend drug or not, must carry on the label the following information: the prescription number; the date of filling; the patient's name; directions for use; the name and strength of the drug and the amount dispensed, including either the brand name of the drug or, if a generic and therapeutically equivalent drug or interchangeable biological product is dispensed the label must be in accordance with section 13781; the beyond use date of the drug; the name of the practitioner prescribing the drug; and the name, address and telephone number of the pharmacy where the prescription was compounded and dispensed. For purposes of this section, "beyond use date" means a date beyond which the contents of the prescription are not recommended to be used.   [PL 2019, c. 34, §5 (AMD).]A drug dispensed in accordance with the provisions of Title 22, chapter 251, subchapter 3, article 5 does not require the name of the patient's sexual partner on the label.   [PL 2009, c. 533, §5 (NEW).]SECTION HISTORY PL 1987, c. 710, §5 (NEW). PL 1999, c. 130, §14 (AMD). PL 2009, c. 533, §5 (AMD). PL 2019, c. 34, §5 (AMD).
32 ME Rev Stat § 13797 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13797. Prescription drug price information

 §13797. Prescription drug price information A pharmacist or person acting at the direction of a pharmacist who is asked for consumer price information regarding prescription drugs shall provide to the consumer, on the telephone or in person, depending on the circumstances, the current usual and customary price for cash customers and, if reasonably obtainable by the pharmacist or person acting at the direction of the pharmacist, the price applicable to the consumer. A pharmacy shall post a notice to consumers informing them that they may obtain current usual and customary price information from the pharmacist.   [PL 2005, c. 610, §1 (NEW).]SECTION HISTORY PL 2005, c. 610, §1 (NEW).
32 ME Rev Stat § 13798 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13798. Expedited partner therapy

 §13798. Expedited partner therapy An individual licensed under this chapter may not be disciplined for dispensing drugs pursuant to a lawful prescription in accordance with the provisions of Title 22, chapter 251, subchapter 3, article 5.   [PL 2009, c. 533, §6 (NEW).]SECTION HISTORY PL 2009, c. 533, §6 (NEW).
32 ME Rev Stat § 13799 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13799. Consumer choice preserved

 §13799. Consumer choice preserved Nothing in this chapter may be construed to prohibit:   [PL 2013, c. 373, §2 (NEW).]1.  Ordering or receiving prescription drugs.  An individual who is a resident of the State from ordering or receiving prescription drugs for that individual’s personal use from outside the United States by mail or carrier from a licensed retail pharmacy described in section 13731, subsection 1, paragraph B or an entity described in section 13731, subsection 1, paragraph C; or   [PL 2013, c. 373, §2 (NEW).] 2.  Dispensing or providing prescription drugs.  A licensed retail pharmacy described in section 13731, subsection 1, paragraph B or an entity described in section 13731, subsection 1, paragraph C from dispensing, providing or facilitating the provision of prescription drugs from outside the United States by mail or carrier to a resident of the State for that resident's personal use.   [PL 2013, c. 373, §2 (NEW).] SECTION HISTORY PL 2013, c. 373, §2 (NEW).
32 ME Rev Stat § 13800 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13800. Access to distributed drugs

 §13800. Access to distributed drugs A manufacturer or wholesaler licensed under section 13758 shall make a drug distributed in this State available for sale in this State to an eligible product developer for purposes of conducting testing required to support an application for approval of a drug under the Federal Food, Drug, and Cosmetic Act, Section 505(b) or 505(j) or the licensing of a biological product under the federal Public Health Service Act, Section 351.   [PL 2017, c. 434, §5 (NEW).]The manufacturer or wholesaler licensed under section 13758 shall make the drug available for sale at a price no greater than the wholesale acquisition cost and without any restriction that would block or delay the eligible product developer's application in a manner inconsistent with Section 505‑1(f)(8) of the Federal Food, Drug, and Cosmetic Act, 21 United States Code, Section 355‑1(f)(8) (2016).   [PL 2017, c. 434, §5 (NEW).]An eligible product developer that receives a drug at a price no greater than the wholesale acquisition cost for that drug pursuant to this section shall charge consumers in this State the same price or less for the drug manufactured by that eligible product developer.   [PL 2017, c. 434, §5 (NEW).]As used in this section, "wholesale acquisition cost" means the manufacturer's list price for a brand-name drug or a generic drug per person per year or course of treatment when sold to wholesalers or direct purchasers in the United States, not including discounts or rebates, for the most recent month for which information is available.   [PL 2017, c. 434, §5 (NEW).]SECTION HISTORY PL 2017, c. 434, §5 (NEW).
32 ME Rev Stat § 13800-A (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13800-A. Liability for product of another; exemption

 §13800-A. Liability for product of another; exemption A manufacturer or wholesaler licensed under section 13758 is not liable for injuries alleged to have been caused by the failure to include adequate safety warnings on a product's label or by a defect in the product's design if:   [PL 2017, c. 434, §5 (NEW).]1.  Access to distributed drugs.  The manufacturer or wholesaler has made the product distributed in this State available to an eligible product developer in accordance with section 13800; and   [PL 2017, c. 434, §5 (NEW).] 2.  Manufactured or sold by another.  The product was not manufactured or sold by that manufacturer or wholesaler.   [PL 2017, c. 434, §5 (NEW).] SECTION HISTORY PL 2017, c. 434, §5 (NEW).
32 ME Rev Stat § 13800-B (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13800-B. Prohibition on providing conversion therapy to minors

 §13800-B. Prohibition on providing conversion therapy to minors An individual licensed under this chapter may not advertise, offer or administer conversion therapy to a minor.   [PL 2019, c. 165, §30 (NEW).]SECTION HISTORY PL 2019, c. 165, §30 (NEW).
32 ME Rev Stat § 13800-C (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13800-C. Opioid medication product registration fee

 §13800-C. Opioid medication product registration fee (CONTAINS TEXT WITH VARYING EFFECTIVE DATES)This section governs opioid medication product registration fees. As used in this section, "unit of an opioid medication" means the lowest identifiable quantity of the opioid medication that is dispensed.   [PL 2019, c. 536, §4 (NEW).]1.  Registration fee.  Except as provided in subsection 2, a manufacturer that sells, delivers or distributes an opioid medication in this State shall pay an annual registration fee of $250,000 to the board on December 31st of each year.   [PL 2019, c. 536, §4 (NEW).] 2.  Exception.  A manufacturer that does not sell, deliver or distribute 2,000,000 or more units of an opioid medication within this State in the year in which a registration fee is due is not required to pay the registration fee. To qualify for the exception under this subsection, a manufacturer must demonstrate to the board, by January 31st of the year following the year in which the registration fee is due, in a manner determined by the board, that the manufacturer did not sell, deliver or distribute 2,000,000 or more units of an opioid medication within this State in the year in which the manufacturer seeks to claim the exception. The board may adopt rules to implement this section. Rules adopted pursuant to this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A.   [PL 2019, c. 536, §4 (NEW).] 3.  Calculation of units of an opioid medication sold, delivered or distributed.  When calculating the number of units of an opioid medication sold, delivered or distributed by a manufacturer under subsection 2, units of an opioid medication may be excluded when prescribed for the purpose of medication-assisted treatment of substance use disorder. The board periodically shall provide to the Department of Health and Human Services a list of medications exempted under this subsection.   [PL 2019, c. 536, §4 (NEW).] 4.  (TEXT EFFECTIVE UNTIL 9/1/23) (TEXT REPEALED 9/1/23) Registration fee review and report.  By March 1st of each year following calendar years 2020, 2021 and 2022, the board shall evaluate and report whether the registration fee due under this section and the fee due under section 13724 have affected the prescribing practices of opioid medications by reducing the number of opioid medication prescriptions issued during calendar years 2020, 2021 and 2022 or whether the fees have created any unintended consequences in the availability of opioid medications for the treatment of chronic or intractable pain, to the extent the board has the ability to identify a correlation. The board shall provide the report to the joint standing committee of the Legislature having jurisdiction over health and human services matters, which may report out legislation based upon the report.   This subsection is repealed September 1, 2023.   [PL 2019, c. 536, §4 (NEW).] SECTION HISTORY PL 2019, c. 536, §4 (NEW).
32 ME Rev Stat § 13800-D (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 9: MISCELLANEOUS PROVISIONS|32 §13800-D. Insulin product registration fee (WHOLE SECTION TEXT EFFECTIVE UNTIL 1/01/27) (WHOLE SECTION TEXT REPEALED 1/01/27)

 §13800-D. Insulin product registration fee (CONTAINS TEXT WITH VARYING EFFECTIVE DATES)(WHOLE SECTION TEXT EFFECTIVE UNTIL 1/01/27)(WHOLE SECTION TEXT REPEALED 1/01/27)This section governs insulin product registration fees. As used in this section, "unit of insulin" means the lowest identifiable quantity of insulin that is dispensed.   [PL 2021, c. 303, §5 (NEW).]1.  Registration fee.  Except as provided in subsection 2, a manufacturer that produces insulin that is sold, delivered or distributed in this State shall pay an annual registration fee of $75,000 to the board on December 31st of each year in addition to any license renewal fee required to be paid by the manufacturer under this chapter.   [PL 2021, c. 303, §5 (NEW).] 2.  Exception.  A manufacturer whose aggregate total of insulin sold, delivered or distributed in this State does not exceed 500,000 units of insulin in the year in which a registration fee under subsection 1 is due is not required to pay the registration fee. To qualify for the exception under this subsection, a manufacturer must demonstrate to the board, by January 31st of the year following the year in which the registration fee is due, in a manner determined by the board, that the aggregate total of insulin produced by the manufacturer that was sold, delivered or distributed within this State in the year in which the manufacturer seeks to claim the exception did not exceed 500,000 units. The board may adopt rules to implement this section. Rules adopted pursuant to this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2-A.   [PL 2021, c. 303, §5 (NEW).] This section is repealed January 1, 2027.   [PL 2021, c. 303, §5 (NEW).]SECTION HISTORY PL 2021, c. 303, §5 (NEW).
32 ME Rev Stat § 13801 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 10: NONDISCRIMINATION IN PHARMACEUTICALS PRICING|32 §13801. Definitions (REPEALED)

 §13801. Definitions (REPEALED)SECTION HISTORY PL 1993, c. 716, §6 (NEW). PL 1999, c. 574, §1 (RP).
32 ME Rev Stat § 13802 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 10: NONDISCRIMINATION IN PHARMACEUTICALS PRICING|32 §13802. Price discrimination prohibited (REPEALED)

 §13802. Price discrimination prohibited (REPEALED)SECTION HISTORY PL 1993, c. 716, §6 (NEW). PL 1999, c. 574, §1 (RP).
32 ME Rev Stat § 13803 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 10: NONDISCRIMINATION IN PHARMACEUTICALS PRICING|32 §13803. Purchases by State (REPEALED)

 §13803. Purchases by State (REPEALED)SECTION HISTORY PL 1993, c. 716, §6 (NEW). PL 1999, c. 574, §1 (RP).
32 ME Rev Stat § 13804 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 10: NONDISCRIMINATION IN PHARMACEUTICALS PRICING|32 §13804. Exceptions (REPEALED)

 §13804. Exceptions (REPEALED)SECTION HISTORY PL 1993, c. 716, §6 (NEW). PL 1995, c. 548, §1 (AMD). PL 1999, c. 574, §1 (RP).
32 ME Rev Stat § 13805 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 10: NONDISCRIMINATION IN PHARMACEUTICALS PRICING|32 §13805. Enforcement (REPEALED)

 §13805. Enforcement (REPEALED)SECTION HISTORY PL 1993, c. 716, §6 (NEW). PL 1999, c. 574, §1 (RP).
32 ME Rev Stat § 13810 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 11: NONCONTROLLED PRESCRIPTION DRUG DISPENSING AND ADMINISTRATION|32 §13810. Drug administration by nurses under certain conditions

 §13810. Drug administration by nurses under certain conditions A professional nurse or an advanced practice registered nurse who is an employee of a home health care provider, as defined in Title 22, section 2142, subsection 3, or a hospice program or hospice provider, as defined in Title 22, section 8621, subsection 10, may:   [PL 1997, c. 109, §1 (NEW).]1.  Possession.  Possess, in the course of employment, such noncontrolled prescription drugs as are approved by the board. In adopting the rules the board shall consult with the Board of Licensure in Medicine, the Board of Osteopathic Licensure, the State Board of Nursing, the Maine Hospice Council, the Department of Health and Human Services and the Home Care Alliance of Maine. Rules adopted pursuant to this subsection are routine technical rules as defined by Title 5, chapter 375, subchapter II‑A; and   [PL 1997, c. 109, §1 (NEW); PL 2003, c. 689, Pt. B, §6 (REV).] 2.  Administration.  Administer, in the course of employment, such drugs as are approved under subsection 1 according to written protocols approved annually by the employer's professional advisory committee, which must include a physician licensed under chapter 36 or chapter 48.   [PL 1997, c. 109, §1 (NEW).] SECTION HISTORY PL 1997, c. 109, §1 (NEW). PL 2003, c. 689, §B6 (REV).
32 ME Rev Stat § 13811 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 11: NONCONTROLLED PRESCRIPTION DRUG DISPENSING AND ADMINISTRATION|32 §13811. Drug administration by certified midwives under certain conditions (WHOLE SECTION TEXT EFFECTIVE UNTIL CONTINGENCY: See PL 2015, c. 502, §16)

 §13811. Drug administration by certified midwives under certain conditions (CONTAINS TEXT WITH VARYING EFFECTIVE DATES)(WHOLE SECTION TEXT EFFECTIVE UNTIL CONTINGENCY: See PL 2015, c. 502, §16)A midwife who can verify to a licensed pharmacist by certification card that the midwife has met the certification standards of an international certification agency whose mission is to establish and administer certification for the credential of certified professional midwife or other certifying body recognized by the board may:   [PL 2007, c. 669, §1 (NEW).]1.  Possession.  Possess, in the course of the practice of midwifery, only the noncontrolled prescription drugs and substances set out in this subsection:   A. Oxygen;   [PL 2007, c. 669, §1 (NEW).]B. Oxytocin, excluding the oxytocic drug methergine, for the sole purpose of postpartum control of maternal hemorrhage;   [PL 2007, c. 669, §1 (NEW).]C. Vitamin K;   [PL 2007, c. 669, §1 (NEW).]D. Eye prophylaxis; and   [PL 2007, c. 669, §1 (NEW).]E. Local anesthetics or numbing agents for repair of lacerations; and   [PL 2007, c. 669, §1 (NEW).][PL 2007, c. 669, §1 (NEW).] 2.  Administration.  Administer, in the course of the practice of midwifery, those drugs that are listed in subsection 1. When administering oxytocin, a certified midwife may not administer more than 20 units of oxytocin to a single patient. Oxytocin may be administered only for postpartum purposes in order to treat hemorrhaging and specifically may not be used to induce labor. When a certified midwife administers oxytocin in accordance with this subsection, the certified midwife shall report that use to the maternal and child health division of the Department of Health and Human Services, the Maine Center for Disease Control and Prevention within 7 days of the use of oxytocin.   [PL 2007, c. 669, §1 (NEW).] SECTION HISTORY PL 2007, c. 669, §1 (NEW). PL 2015, c. 502, §12 (RP). PL 2015, c. 502, §16 (AFF).
32 ME Rev Stat § 13811 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 11: NONCONTROLLED PRESCRIPTION DRUG DISPENSING AND ADMINISTRATION|32 §13811. Drug administration by certified midwives under certain conditions (WHOLE SECTION TEXT REPEALED ON CONTINGENCY: See PL 2015, c. 502, §16) (REPEALED)

 §13811. Drug administration by certified midwives under certain conditions (CONTAINS TEXT WITH VARYING EFFECTIVE DATES)(WHOLE SECTION TEXT REPEALED ON CONTINGENCY: See PL 2015, c. 502, §16)(REPEALED)SECTION HISTORY PL 2007, c. 669, §1 (NEW). PL 2015, c. 502, §12 (RP). PL 2015, c. 502, §16 (AFF).
32 ME Rev Stat § 13812 (2021)
2021 Maine Revised Statutes|TITLE 32: PROFESSIONS AND OCCUPATIONS|Chapter 117: MAINE PHARMACY ACT|Subchapter 11: NONCONTROLLED PRESCRIPTION DRUG DISPENSING AND ADMINISTRATION|32 §13812. Dispensing of medication by pharmacist (WHOLE SECTION TEXT EFFECTIVE UNTIL CONTINGENCY: See PL 2015, c. 502, §16)

 §13812. Dispensing of medication by pharmacist (CONTAINS TEXT WITH VARYING EFFECTIVE DATES)(WHOLE SECTION TEXT EFFECTIVE UNTIL CONTINGENCY: See PL 2015, c. 502, §16)1.  Dispensing of medication.  A pharmacist, who in good faith relies upon a certification card presented by a midwife identifying that the midwife has met the certification standards described under section 13811, may sell and dispense to the midwife the noncontrolled prescription drugs and substances identified in section 13811.   [PL 2007, c. 669, §2 (NEW).] 2.  Good faith.  A pharmacist, or person acting at the direction of a pharmacist, who:   A. In good faith sells and dispenses noncontrolled prescription drugs and substances to a midwife pursuant to this section is not liable for any adverse reactions caused by any method of use by the midwife; and   [PL 2007, c. 669, §2 (NEW).]B. Makes a report relating to the dispensing of noncontrolled prescription drugs and substances to a midwife pursuant to section 13811 to an enforcement agency is immune from any civil liability that may result from that action, including, but not limited to, any civil liability that might otherwise arise under state or local laws or rules regarding confidentiality of information.   [PL 2007, c. 669, §2 (NEW).]In a proceeding in which a pharmacist, or person acting at the direction of a pharmacist, invokes the immunity provided pursuant to this section, there is a rebuttable presumption of good faith.   [PL 2007, c. 669, §2 (NEW).] SECTION HISTORY PL 2007, c. 669, §2 (NEW). PL 2015, c. 502, §13 (RP). PL 2015, c. 502, §16 (AFF).